Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Erythropoietic Porphyria (CEP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07820085
What this trial is testing

Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)EPP2
Portal Therapeutics, Inc. 225
Large-scale testing (Phase 3)Study completedNCT00004940
What this trial is testing

Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Brigham and Women's Hospital 50
Large-scale testing (Phase 3)Study completedNCT04053270
What this trial is testing

Multicentre Phase III Erythropoietic Protoporphyria Study

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 100
Not applicableStudy completedNCT01568554
What this trial is testing

Clinical Diagnosis of Acute Porphyria

Who this might be right for
Hereditary Coproporphyria (HCP)Acute Intermittent Porphyria (AIP)Variegate Porphyria (VP)
University of California, San Francisco 148
Not applicableStudy completedNCT00005103
What this trial is testing

Study of the Pathogenesis of Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
National Center for Research Resources (NCRR) 120
Testing effectiveness (Phase 2)Study completedNCT00004789
What this trial is testing

Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 59
Testing effectiveness (Phase 2)Study completedNCT05020184
What this trial is testing

Effect of Oral Cimetidine in the Protoporphyrias

Who this might be right for
Erythropoietic ProtoporphyriaX-linked Protoporphyria
Amy K. Dickey, M.D. 26
Testing effectiveness (Phase 2)Study completedNCT01097044
What this trial is testing

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 77
Not applicableEnded earlyNCT01550705
What this trial is testing

Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria (EPP)X Linked Erythropoietic Protoporphyria
University of Utah 11
Not applicableStudy completedNCT03906214
What this trial is testing

Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria

Who this might be right for
Porphyrias
University of South Florida 60
Not applicableUnknownNCT01617642
What this trial is testing

Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)

Who this might be right for
Acute Intermittent Porphyria
Nordlandssykehuset HF 100
Not applicableStudy completedNCT01880983
What this trial is testing

Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))

Who this might be right for
Erythropoietic Protoporphyria (EPP)
University of Alabama at Birmingham 150
Not applicableLooking for participantsNCT04883905
What this trial is testing

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

Who this might be right for
Acute Hepatic Porphyria
Alnylam Pharmaceuticals 150
Early research (Phase 1)Study completedNCT02452372
What this trial is testing

Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT00418795
What this trial is testing

Porphozym in the Treatment of Acute Attacks in AIP

Who this might be right for
Acute Intermittent Porphyria
Zymenex A/S 36
Early research (Phase 1)Study completedNCT00004398
What this trial is testing

Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 24
Testing effectiveness (Phase 2)Study completedNCT03520036
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria (EPP)
Tanabe Pharma America, Inc. 102
Not applicableLooking for participantsNCT07567131
What this trial is testing

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Porphyria (XLP)
Portal Therapeutics, Inc. 50
Early research (Phase 1)Study completedNCT03505853
What this trial is testing

Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria (AIP)Acute Hepatic Porphyria (AHP)Porphyria, Acute Intermittent+1 more
Alnylam Pharmaceuticals 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06910358
What this trial is testing

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc 183
Next Page